£
We use cookies to improve your experience. By accepting you agree to our cookie policy
Project Title
The effectiveness of western and complementary and alternative medicine (CAM) modalities on chronic pain due to complex regional pain syndrome (CRPS).
Purpose of the Study
Respondents are being asked to participate in a research study evaluating the effectiveness of various treatments on chronic pain due to complex regional pain syndrome (CRPS). The short survey is anonymous and confidential, and should take approximately five minutes to complete. The questions will focus on the modalities used to manage chronic pain due to CRPS and will include a Likert scale to rate pain levels after using these interventions.
Risks & Benefits
There are minimal risks in completing this survey about CRPS modalities. If an individual has CRPS in their hand/arm, the motion of using a computer mouse or cell phone may trigger pain, but that is largely dependent upon the individual. Respondents may take as many breaks as needed while completing the survey. If while completing the survey, the respondent feels any emotional, mental, or physical distress, they may exit the survey at any time. Participating in this survey will benefit the treatment and understanding of CRPS for both individuals with CRPS and the medical community.
Eligibility
Participants must be 18 years of age, provide an electronic signature on a consent form, and have experienced chronic pain for at least six months.
Procedures
Participants must read and provide consent on this form. Participants are being asked to complete this simple survey (https://forms.gle/tDzUKvqcKRZYgWpeA) regarding their experiences with chronic pain due to complex regional pain syndrome. The initial link will direct participants to a consent form. After completing the consent form, participants will receive a link to the survey. Please note the data collection window will be closing on June 20, 2026.
Confidentiality
Survey responses will be kept confidential. Data will be secured and will be available only to the research team. Results will be reported without identifying the participants. The survey will be anonymous, so participants will not be at risk of being identified. Since the survey is anonymous, participants will not be at risk of being identified by the modalities they have used, the dosage, or the medication prescribed. The survey and research will adhere to the present HIPAA guidelines. Data will be stored in a password-protected Google Drive file for safekeeping. The data will be retained for three years, as recommended by most federal agencies and journals. This study has been approved by Concordia St. Paul Institutional Review Board (IRB), Study Number 2025_068.
Contact Information
For questions regarding this study, please contact Sarah Tritini at tritinis@csp.edu.
We use cookies to improve your experience. By accepting you agree to our cookie policy